KB-5246 is a tetracyclic quinolone with antibacterial activity; it is effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Streptococcus pyogenes (MIC90 = 0.39 μg/mL); it also inhibits Gram-negative bacteria such as Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at concentrations of ≤0.10 μg/mL; in vivo, it shows efficacy against infections caused by S. pneumoniae (ED50 = 50.5 mg/kg), S. aureus, Pseudomonas aeruginosa, and Serratia marcescens, with activity comparable to ofloxacin and superior to norfloxacin.